To access this element change to forms mode OFF
Grant Award View - GA66011
Understanding the basis for IRF4 dependency in Multiple Myeloma
GA ID:
GA66011
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2023
Value (AUD):
$1,142,147.70
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Understanding the basis for IRF4 dependency in Multiple Myeloma
Purpose:
Multiple myeloma (MM) is a common cancer that, despite new treatment options remains incurable. We have identified a protein called IRF4 as being essential for MM cell survival. Thus we predict that a drug that targets IRF4 would represent an excellent new approach to treat MM. We have developed an innovative new experimental system to probe the IRF4 molecule to identify new areas of weakness and aim to translate this knowledge into new anti-IRF4 drugs that we can develop to treat MM.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1184523
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA